| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2579610 | Thérapie | 2007 | 5 Pages |
Abstract
The excess of NSS in schizophrenic patients is independent of the neuroleptic treatment, suggesting that NSS represent a neurodevelopmental risk factor for schizophrenia.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
Anwar Mechri, Héla Slama, Sabeur Chebel, Olfa Mandhouj, Lotfi Gaha,